Target ALS Awards 4 Grants for Work Into Biomarker Discovery
Target ALS, a nonprofit working to advance research, has awarded a second round of grants supporting four projects that…
Articles by Marisa Wexler, MS
QurAlis Working on New ALS Therapy to Harness Benefits Without Side Effects
Researchers at QurAlis have discovered a molecule with the potential to act as a treatment for amyotrophic lateral…
Ezogabine Decreases Motor Neuron Excitability in ALS Clinical Trial
The anticonvulsant ezogabine can significantly reduce abnormal motor neuron excitability in people with amyotrophic lateral…
Bill Easing Access to Disability Benefits for ALS Patients Passes US Senate
The U.S. Senate has passed a bill that may make it easier for people with amyotrophic lateral sclerosis (ALS)…
Wearable Facial Sensor May Help ALS Patients More Easily Communicate
A lightweight, wearable sensor is being developed that can detect minute facial movements and translate them into messages, potentially helping…
Combo Bone Marrow Cell Transplant Seen to Benefit Mice in ALS Model
Transplanting a combination of two types of modified bone marrow cells eased motor deficits and prolonged survival in a mouse model…
NORD Hosting ‘RareLaunch’ Workshops to Help Start Rare Disease Non-profits
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
Possible Way Seen of Preventing Inflammation That Precedes ALS Onset
Toxic clumps due to the buildup of the TDP-43 protein can trigger the neuronal inflammation that precedes symptoms of amyotrophic lateral…
Telehealth ‘Helpful’ Alternative to In-person Care, Rare Disease Patients Say
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
$2M NIH Grant Supports Work Into Cell Structures Linked to ALS Protein Clumps
A $2 million grant from the National Institutes of Health (NIH) is funding work to better understand how molecular…